Humedica raises $20M, plans to double workforce

Boston-based health informatics company Humedica has banked a $20 million equity round and plans to use the money to double its workforce to 100 people by the end of this year. The company--which provides "clinical business intelligence"--revealed the round in SEC documents, according to Mass High Tech. Story

Suggested Articles

The NIH is starting with Eli Lilly and AbCellera's COVID-19 antibody but could add more prospects as the trial goes on.

The series B positions ex-AveXis executives to build a biotech with a broad gene therapy pipeline and infrastructure to match.

A variant of the ACE2 receptor could work as a COVID-19 therapeutic by drawing the virus away from healthy cells, scientists reported.